{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:15:48Z","timestamp":1791389748208,"version":"4.3.3"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI-0727-2010"],"award-info":[{"award-number":["PI-0727-2010"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PI13\/00593"],"award-info":[{"award-number":["PI13\/00593"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["BFU2017-83588-P"],"award-info":[{"award-number":["BFU2017-83588-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PI10\/00871"],"award-info":[{"award-number":["PI10\/00871"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["2-SRA-2019-837-S-B"],"award-info":[{"award-number":["2-SRA-2019-837-S-B"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","award":["17-2013-372"],"award-info":[{"award-number":["17-2013-372"]}],"id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010566","name":"Consejer\u00eda de Salud, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001067","name":"Juvenile Diabetes Research Foundation Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["BFU2017-83588-P"],"award-info":[{"award-number":["BFU2017-83588-P"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI13\/00593"],"award-info":[{"award-number":["PI13\/00593"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI10\/00871"],"award-info":[{"award-number":["PI10\/00871"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P10.CTS.6359"],"award-info":[{"award-number":["P10.CTS.6359"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.metabol.2020.154137","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T11:57:53Z","timestamp":1577966273000},"page":"154137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration"],"prefix":"10.1016","volume":"104","author":[{"given":"Nadia","family":"Cobo-Vuilleumier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit R.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154137_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.it.2013.10.006","article-title":"SeXX matters in immunity","volume":"35","author":"Markle","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fendo.2019.00265","article-title":"Autoimmune disease in women: endocrine transition and risk across the lifespan","volume":"10","author":"Desai","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2020.154137_bb0015","series-title":"The cost burden of autoimmune disease","author":"AARDA, NCAPG","year":"2011"},{"key":"10.1016\/j.metabol.2020.154137_bb0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diabetes.54.5.1253","article-title":"Outstanding scientific achievement lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can\u2019t we prevent or reverse this disease?","volume":"54","author":"Atkinson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0025","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/90935","article-title":"Autoimmune disease: why and where it occurs","volume":"7","author":"Marrack","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2020.154137_bb0030","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3389\/fimmu.2019.01525","article-title":"The role of epigenetics in autoimmune\/inflammatory disease","volume":"10","author":"Surace","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0035","series-title":"Achenbach P","author":"Bonifacio","year":"2019"},{"key":"10.1016\/j.metabol.2020.154137_bb0040","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2020.154137_bb0045","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/S0140-6736(16)30507-4","article-title":"Environmental risk factors for type 1 diabetes","volume":"387","author":"Rewers","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2020.154137_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/pedi.12659","article-title":"A plateau in new onset type 1 diabetes: incidence of pediatric diabetes in the United States military health system","volume":"19","author":"Rush","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","article-title":"Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study","volume":"62","author":"Patterson","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2020.154137_bb0060","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/pedi.12636","article-title":"Incidence of childhood onset type 1 diabetes in Western Australia from 1985 to 2016: evidence for a plateau","volume":"19","author":"Haynes","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2337\/db10-0813","article-title":"Swedish Childhood Diabetes Study G. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden","volume":"60","author":"Berhan","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.2013.8399","article-title":"Incidence of type 1 diabetes in Finland","volume":"310","author":"Harjutsalo","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2020.154137_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00125-013-3090-y","article-title":"Norwegian Childhood Diabetes Study G. Incidence of type 1 diabetes in Norway among children aged 0-14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian childhood diabetes registry","volume":"57","author":"Skrivarhaug","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2020.154137_bb0080","first-page":"360","article-title":"Incidence of type 1 diabetes in China, 2010-13: population based study","volume":"j5295","author":"Weng","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2020.154137_bb0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1210\/er.2017-00191","article-title":"Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms","volume":"39","author":"Corbin","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2020.154137_bb0090","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2020.154137_bb0095","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/dme.13983","article-title":"Socio-economic, demographic, and clinical correlates of poor glycaemic control within insulin regimens among children with type 1 diabetes: the SEARCH for diabetes in youth study","volume":"36","author":"Snyder","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2020.154137_bb0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1021\/acs.biochem.8b01118","article-title":"Targeting type 1 diabetes: selective approaches for new therapies","volume":"58","author":"Sheehy","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.metabol.2020.154137_bb0105","doi-asserted-by":"crossref","unstructured":"Vantyghem MC, de Koning EJP, Pattou F, Rickels MR. Advances in beta-cell replacement therapy for the treatment of type 1 diabetes. Lancet 2019.","DOI":"10.1016\/S0140-6736(19)31334-0"},{"key":"10.1016\/j.metabol.2020.154137_bb0110","unstructured":"CITR, https:\/\/citregistry.org\/ accessed August 7th 2019."},{"key":"10.1016\/j.metabol.2020.154137_bb0115","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3389\/fimmu.2018.01354","article-title":"Regenerative medicine, and bioengineering for type 1 diabetes","volume":"9","author":"Kopan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2337\/db18-0788","article-title":"Posttransplant characterization of long-term functional hESC-derived pancreatic endoderm grafts","volume":"68","author":"Pepper","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0125","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14712598.2015.1066330","article-title":"Using stem cells to produce insulin","volume":"15","author":"Soria","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.metabol.2020.154137_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2016.05.016","article-title":"Immune therapy in type 1 diabetes mellitus - attempts to untie the Gordian knot?","volume":"65","author":"Perakakis","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2020.154137_bb0135","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00125-009-1644-9","article-title":"Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass","volume":"53","author":"Keymeulen","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2020.154137_bb0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","article-title":"Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.metabol.2020.154137_bb0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, Teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154137_bb0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/dmrr.2503","article-title":"GAD-treatment of children and adolescents with recent-onset type 1 diabetes preserves residual insulin secretion after 30 months","volume":"30","author":"Ludvigsson","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.metabol.2020.154137_bb0155","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/14712598.2017.1328495","article-title":"GAD65: a prospective vaccine for treating type 1 diabetes?","volume":"17","author":"Ludvigsson","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.metabol.2020.154137_bb0160","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.4049\/jimmunol.181.12.8298","article-title":"Improved efficacy of a tolerizing DNA vaccine for reversal of hyperglycemia through enhancement of gene expression and localization to intracellular sites","volume":"181","author":"Solvason","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0165","doi-asserted-by":"crossref","unstructured":"Roep BO, Solvason N, Gottlieb PA, Abreu JR, Harrison LC, Eisenbarth GS, et al. Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8(+) T cells in type 1 diabetes. Sci Transl Med. 2013;5:191ra82.","DOI":"10.1126\/scitranslmed.3006103"},{"key":"10.1016\/j.metabol.2020.154137_bb0170","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/eji.201546005","article-title":"Interleukin-1 antagonism moderates the inflammatory state associated with type 1 diabetes during clinical trials conducted at disease onset","volume":"46","author":"Cabrera","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0175","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S2213-8587(14)70115-9","article-title":"Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial","volume":"2","author":"Griffin","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2020.154137_bb0180","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2020.154137_bb0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ni.3659","article-title":"Postprandial macrophage-derived IL-1beta stimulates insulin, and both synergistically promote glucose disposal and inflammation","volume":"18","author":"Dror","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0190","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86055","article-title":"Interleukin-1 signaling contributes to acute islet compensation","volume":"1","author":"Hajmrle","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2020.154137_bb0195","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.2337\/db05-1034","article-title":"Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes","volume":"55","author":"Sherry","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/db13-0204","article-title":"Soluble factors secreted by T cells promote beta-cell proliferation","volume":"63","author":"Dirice","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4107943","article-title":"Cotransplantation of mesenchymal stem cells and immature dendritic cells potentiates the blood glucose control of islet allografts","volume":"2017","author":"Long","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2020.154137_bb0210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.molmet.2015.05.002","article-title":"Macrophages are essential for CTGF-mediated adult beta-cell proliferation after injury","volume":"4","author":"Riley","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0215","doi-asserted-by":"crossref","first-page":"E1211","DOI":"10.1073\/pnas.1321347111","article-title":"M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7","volume":"111","author":"Xiao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154137_bb0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fendo.2019.00101","article-title":"Endogenous pancreatic beta cell regeneration: a potential strategy for the recovery of beta cell deficiency in diabetes","volume":"10","author":"Zhong","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2020.154137_bb0225","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s42255-019-0061-8","article-title":"Increased beta-cell proliferation before immune cell invasion prevents progression of type 1 diabetes","volume":"1","author":"Dirice","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0230","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/hmg\/ddm325","article-title":"The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1","volume":"17","author":"Brun","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2020.154137_bb0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrendo.2015.9","article-title":"Diabetes mellitus--advances and challenges in human beta-cell proliferation","volume":"11","author":"Wang","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2020.154137_bb0240","doi-asserted-by":"crossref","unstructured":"P. W, Karakose E, Liu H, Swartz E, Ackeifi C, Zlatanic V, et al. Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells. Cell metabolism. 2019;29.","DOI":"10.1016\/j.cmet.2018.12.005"},{"key":"10.1016\/j.metabol.2020.154137_bb0245","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/stem.482","article-title":"Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells","volume":"28","author":"Chung","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.metabol.2020.154137_bb0250","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08894","article-title":"Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss","volume":"464","author":"Thorel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154137_bb0255","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/s41467-018-03943-0","article-title":"LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus","volume":"9","author":"Cobo-Vuilleumier","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2020.154137_bb0260","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41556-018-0216-y","article-title":"Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon(+) alpha-cells","volume":"20","author":"Cigliola","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cell.2009.05.035","article-title":"The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells","volume":"138","author":"Collombat","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2020.154137_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003934","article-title":"The inactivation of Arx in pancreatic alpha-cells triggers their neogenesis and conversion into functional beta-like cells","volume":"9","author":"Courtney","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2020.154137_bb0275","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2015.181","article-title":"PAX4 gene transfer induces alpha-to-beta Cell phenotypic conversion and confers therapeutic benefits for diabetes treatment","volume":"24","author":"Zhang","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.metabol.2020.154137_bb0280","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-016-3864-0","article-title":"PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus","volume":"59","author":"Mellado-Gil","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2020.154137_bb0285","doi-asserted-by":"crossref","unstructured":"Ben-Othman N, Vieira A, Courtney M, Record F, Gjernes E, Avolio F, et al. Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis. Cell. 2017;168:73\u201385 e11.","DOI":"10.1016\/j.cell.2016.11.002"},{"key":"10.1016\/j.metabol.2020.154137_bb0290","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cmet.2018.07.002","article-title":"GABA and Artesunate do not induce pancreatic alpha-to-beta Cell Transdifferentiation in vivo","volume":"28","author":"Ackermann","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0295","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cmet.2017.10.002","article-title":"Artemether does not turn alpha cells into beta cells","volume":"27","author":"van der Meulen","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0300","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41574-018-0101-6","article-title":"Can GABA turn pancreatic alpha-cells into beta-cells?","volume":"14","author":"Eizirik","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2020.154137_bb0305","article-title":"Regeneration of pancreatic beta-islet cells in a type-II diabetic","volume":"2018","author":"Jones","year":"2018","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.metabol.2020.154137_bb0310","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2015-2802","article-title":"Beta-Cell glucose sensitivity is linked to insulin\/glucagon bihormonal cells in nondiabetic humans","volume":"101","author":"Mezza","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0315","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.cmet.2017.01.009","article-title":"Converting adult pancreatic islet alpha cells into beta cells by targeting both Dnmt1 and Arx","volume":"25","author":"Chakravarthy","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0320","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-019-0942-8","article-title":"Diabetes relief in mice by glucose-sensing insulin-secreting human alpha-cells","volume":"567","author":"Furuyama","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154137_bb0325","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154137_bb0330","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13167-017-0081-y","article-title":"Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine","volume":"8","author":"Avishai","year":"2017","journal-title":"EPMA J"},{"key":"10.1016\/j.metabol.2020.154137_bb0335","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.aam7928","article-title":"Inflammation and metabolism in tissue repair and regeneration","volume":"356","author":"Eming","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.metabol.2020.154137_bb0340","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chembiol.2011.12.011","article-title":"Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity","volume":"19","author":"Burris","year":"2012","journal-title":"Chem Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0345","first-page":"5667","article-title":"A novel DNA-binding motif abuts the zinc finger domain of insect nuclear hormone receptor FTZ-F1 and mouse embryonal long terminal repeat-binding protein","volume":"12","author":"Ueda","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0350","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1152\/physrev.00019.2018","article-title":"The orphan nuclear receptors steroidogenic factor-1 and liver receptor Homolog-1: structure, regulation, and essential roles in mammalian reproduction","volume":"99","author":"Meinsohn","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2020.154137_bb0355","doi-asserted-by":"crossref","first-page":"13136","DOI":"10.1074\/jbc.M010737200","article-title":"The mouse fetoprotein transcription factor (FTF) gene promoter is regulated by three GATA elements with tandem E box and Nkx motifs, and FTF in turn activates the Hnf3beta, Hnf4alpha, and Hnf1alpha gene promoters","volume":"276","author":"Pare","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.metabol.2020.154137_bb0360","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/dbio.1997.8744","article-title":"The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3beta in the developing murine liver and pancreas","volume":"192","author":"Rausa","year":"1997","journal-title":"Dev Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.stem.2009.12.009","article-title":"The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells","volume":"6","author":"Heng","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.metabol.2020.154137_bb0370","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ceb.2014.10.007","article-title":"Molecular basis for the regulation of the nuclear receptor LRH-1","volume":"33","author":"Stein","year":"2015","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96151","article-title":"LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity","volume":"3","author":"Miranda","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2020.154137_bb0380","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1101\/gad.16860911","article-title":"LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function","volume":"25","author":"Holmstrom","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2020.154137_bb0385","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/MCB.00579-06","article-title":"Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response","volume":"26","author":"Venteclef","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0390","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01694","article-title":"Nuclear receptor LRH-1\/NR5A2 is required and targetable for liver endoplasmic reticulum stress resolution","volume":"3","author":"Mamrosh","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.metabol.2020.154137_bb0395","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1074\/jbc.M608993200","article-title":"Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response","volume":"282","author":"Venteclef","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154137_bb0400","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1101\/gad.545110","article-title":"GPS2-dependent corepressor\/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response","volume":"24","author":"Venteclef","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2020.154137_bb0405","doi-asserted-by":"crossref","first-page":"13098","DOI":"10.1073\/pnas.0702440104","article-title":"LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease","volume":"104","author":"Coste","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154137_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2018.08.009","article-title":"Local synthesis of immunosuppressive glucocorticoids in the intestinal epithelium regulates anti-viral immune responses","volume":"334","author":"Huang","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0415","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1038\/s41467-018-06137-w","article-title":"LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival","volume":"9","author":"Bayrer","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2020.154137_bb0420","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbadis.2010.12.010","article-title":"Emerging actions of the nuclear receptor LRH-1 in the gut","volume":"1812","author":"Fernandez-Marcos","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2020.154137_bb0425","doi-asserted-by":"crossref","unstructured":"Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42:224\u20138.","DOI":"10.1038\/ng.522"},{"key":"10.1016\/j.metabol.2020.154137_bb0430","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/OTT.S157759","article-title":"Association between NR5A2 and the risk of pancreatic cancer, especially among Caucasians: a meta-analysis of case-control studies","volume":"11","author":"Chen","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.metabol.2020.154137_bb0435","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/mc.22604","article-title":"Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers","volume":"56","author":"Luo","year":"2017","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.metabol.2020.154137_bb0440","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/15384047.2015.1045693","article-title":"Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer","volume":"16","author":"Nadolny","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.metabol.2020.154137_bb0445","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2012-304381","article-title":"Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRasG12V-driven pancreatic tumourigenesis","volume":"63","author":"Flandez","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2020.154137_bb0450","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/gutjnl-2012-304287","article-title":"Morris JPt, Wright CV, Hebrok M. Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation","volume":"63","author":"von Figura","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2020.154137_bb0455","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature25751","article-title":"Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas","volume":"554","author":"Cobo","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154137_bb0460","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1128\/MCB.23.19.6713-6724.2003","article-title":"Pancreatic-duodenal homeobox 1 regulates expression of liver receptor homolog 1 during pancreas development","volume":"23","author":"Annicotte","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0465","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/me.2007-0568","article-title":"Research resource: nuclear hormone receptor expression in the endocrine pancreas","volume":"22","author":"Chuang","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2020.154137_bb0470","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/hmg\/ddr193","article-title":"The liver receptor Homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stress-induced apoptosis","volume":"20","author":"Baquie","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2020.154137_bb0475","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddx402","article-title":"The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects beta-cells against stress-induced apoptosis","volume":"27","author":"Baquie","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2020.154137_bb0480","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1093\/nar\/gkt827","article-title":"Co-regulated gene expression by oestrogen receptor alpha and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells","volume":"41","author":"Lai","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2020.154137_bb0485","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI119743","article-title":"Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids","volume":"100","author":"Delaunay","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154137_bb0490","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154137_bb0495","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.11.004","article-title":"Local release of dexamethasone from macroporous scaffolds accelerates islet transplant engraftment by promotion of anti-inflammatory M2 macrophages","volume":"114","author":"Jiang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.metabol.2020.154137_bb0500","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2337\/db11-1054","article-title":"Optimal elevation of beta-Cell 11beta-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced beta-Cell failure","volume":"61","author":"Turban","year":"2012","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154137_bb0505","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/230870","article-title":"Islet \u03b2-cell mass preservation and Regeneration in diabetes mellitus: four factors with potential therapeutic interest","volume":"2012","author":"Mellado-Gil","year":"2012","journal-title":"J Transplant"},{"key":"10.1016\/j.metabol.2020.154137_bb0510","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1038\/ncomms7801","article-title":"LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPARgamma ligand synthesis","volume":"6","author":"Lefevre","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2020.154137_bb0515","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.173","article-title":"Liver receptor homolog-1 (NR5a2) regulates CD95\/Fas ligand transcription and associated T-cell effector functions","volume":"8","author":"Schwaderer","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2020.154137_bb0520","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.173.3.1519","article-title":"Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10","volume":"173","author":"Barreiro","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0525","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJM199611283352204","article-title":"Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity","volume":"335","author":"Drappa","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2020.154137_bb0530","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/373441a0","article-title":"Cell-autonomous Fas (CD95)\/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas","volume":"373","author":"Brunner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154137_bb0535","doi-asserted-by":"crossref","unstructured":"de Jong VM, van der Slik AR, Laban S, van 't Slot R, Koeleman BP, Zaldumbide A, et al. Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes. Genes Immun 2016;17:342\u20138.","DOI":"10.1038\/gene.2016.29"},{"key":"10.1016\/j.metabol.2020.154137_bb0540","doi-asserted-by":"crossref","unstructured":"Seitz C, Huang J, Geiselhoringer AL, Galbani-Bianchi P, Michalek S, Phan TS, et al. The orphan nuclear receptor LRH-1\/NR5a2 critically regulates T cell functions. Sci Adv. 2019;5:eaav9732.","DOI":"10.1126\/sciadv.aav9732"},{"key":"10.1016\/j.metabol.2020.154137_bb0545","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nsmb910","article-title":"Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP","volume":"12","author":"Ortlund","year":"2005","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0550","doi-asserted-by":"crossref","unstructured":"Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, et al. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell. 2005;120:343\u201355.","DOI":"10.1016\/j.cell.2005.01.024"},{"key":"10.1016\/j.metabol.2020.154137_bb0555","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/prot.21661","article-title":"Molecular dynamics simulation study for LRH-1: interaction with fragments of SHP and function of phospholipid ligand","volume":"70","author":"Zhang","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.metabol.2020.154137_bb0560","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S1097-2765(03)00236-3","article-title":"Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1","volume":"11","author":"Sablin","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.metabol.2020.154137_bb0565","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nsmb.2279","article-title":"Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation","volume":"19","author":"Musille","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0570","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10111","article-title":"A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects","volume":"474","author":"Lee","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2020.154137_bb0575","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1021\/jm060990k","article-title":"Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1","volume":"49","author":"Whitby","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2020.154137_bb0580","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10549-010-0994-9","article-title":"The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells","volume":"127","author":"Thiruchelvam","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.metabol.2020.154137_bb0585","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/jm1014296","article-title":"Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2)","volume":"54","author":"Whitby","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2020.154137_bb0590","doi-asserted-by":"crossref","first-page":"25281","DOI":"10.1074\/jbc.M116.753541","article-title":"Crystal structures of the nuclear receptor, liver receptor homolog 1, bound to synthetic agonists","volume":"291","author":"Mays","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154137_bb0595","unstructured":"St-Onge L, Baquie M, Wollheim CB, Gauthier BR. Novel methods for preventing diabetes. Patent WO\/2011\/144725."},{"key":"10.1016\/j.metabol.2020.154137_bb0600","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fendo.2014.00165","article-title":"Beta-cell-specific glucocorticoid reactivation attenuates inflammatory beta-cell destruction","volume":"5","author":"Liu","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2020.154137_bb0605","doi-asserted-by":"crossref","first-page":"141","DOI":"10.15698\/cst2018.06.140","article-title":"Targeting LRH-1\/NR5A2 to treat type 1 diabetes mellitus","volume":"2","author":"Cobo-Vuilleumier","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.metabol.2020.154137_bb0610","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tem.2010.02.008","article-title":"Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis","volume":"21","author":"Brown","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0615","first-page":"PS019","article-title":"Conditional overexpression of Pax4 in pancreatic beta cells protects mice from developing streptozotocin-induced diabetes","volume":"52","author":"Hu He","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2020.154137_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2018.07.004","article-title":"Therapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus","volume":"43","author":"Lorenzo","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.metabol.2020.154137_bb0625","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10863-006-9063-9","article-title":"Galectin-3 in apoptosis, a novel therapeutic target","volume":"39","author":"Nangia-Makker","year":"2007","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.metabol.2020.154137_bb0630","doi-asserted-by":"crossref","first-page":"14496","DOI":"10.1073\/pnas.0903497106","article-title":"Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse","volume":"106","author":"Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154137_bb0635","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3","volume":"180","author":"MacKinnon","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0640","first-page":"2011","article-title":"PAI-1: an integrator of Cell signaling and migration","volume":"562481","author":"Czekay","year":"2011","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.metabol.2020.154137_bb0645","doi-asserted-by":"crossref","unstructured":"Qi L, Higgins SP, Lu Q, Samarakoon R, Wilkins-Port CE, Ye Q, et al. SERPINE1 (PAI-1) is a prominent member of the early G0 --> G1 transition \"wound repair\" transcriptome in p53 mutant human keratinocytes. J Invest Dermatol. United States2008. p. 749\u201353.","DOI":"10.1038\/sj.jid.5701068"},{"key":"10.1016\/j.metabol.2020.154137_bb0650","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/wound.2014.0611","article-title":"Targeted inhibition of PAI-1 activity impairs epithelial migration and wound closure following cutaneous injury","volume":"4","author":"Simone","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"10.1016\/j.metabol.2020.154137_bb0655","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1158\/0008-5472.CAN-06-0479","article-title":"Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition","volume":"66","author":"Moreno-Bueno","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2020.154137_bb0660","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","article-title":"Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene","volume":"17","author":"Dennler","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2020.154137_bb0665","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1021\/pr3002996","article-title":"Discovery of novel glucose-regulated proteins in isolated human pancreatic islets using LC-MS\/MS-based proteomics","volume":"11","author":"Schrimpe-Rutledge","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2020.154137_bb0670","doi-asserted-by":"crossref","unstructured":"Li F, Huang Q, Chen J, Peng Y, Roop DR, Bedford JS, et al. Apoptotic cells activate the \"phoenix rising\" pathway to promote wound healing and tissue regeneration. Sci Signal. 2010;3:ra13.","DOI":"10.1126\/scisignal.2000634"},{"key":"10.1016\/j.metabol.2020.154137_bb0675","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.4049\/jimmunol.0903816","article-title":"Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production","volume":"184","author":"Chan","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0680","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1016\/j.febslet.2005.06.024","article-title":"Protective role for cytosolic phospholipase A2alpha in autoimmune diabetes of mice","volume":"579","author":"Oikawa","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.metabol.2020.154137_bb0685","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/db11-1396","article-title":"PTGS-2-PTGER2\/4 signaling pathway partially protects from diabetogenic toxicity of streptozotocin in mice","volume":"61","author":"Vennemann","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2020.154137_bb0690","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.molmet.2017.04.002","article-title":"Opposing effects of prostaglandin E2 receptors EP3 and EP4 on mouse and human beta-cell survival and proliferation","volume":"6","author":"Carboneau","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0695","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17102-w","article-title":"Oestrogen receptor-alpha binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer","volume":"7","author":"Adurthi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2020.154137_bb0700","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/febs.13827","article-title":"Regulatory T cells and skeletal muscle regeneration","volume":"284","author":"Schiaffino","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.metabol.2020.154137_bb0705","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/1535370216650293","article-title":"Monocytes and macrophages in tissue repair: implications for immunoregenerative biomaterial design","volume":"241","author":"Ogle","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.metabol.2020.154137_bb0710","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-018-4592-4","article-title":"The resident macrophages in murine pancreatic islets are constantly probing their local environment, capturing Beta Cell granules and blood particles","volume":"61","author":"Zinselmeyer","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2020.154137_bb0715","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.20150496","article-title":"The pancreas anatomy conditions the origin and properties of resident macrophages","volume":"212","author":"Calderon","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2020.154137_bb0720","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.immunol.21.120601.141110","article-title":"T cell anergy","volume":"21","author":"Schwartz","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.metabol.2020.154137_bb0725","first-page":"9","article-title":"Pancreatic alpha-cell mass in the early-onset and advanced stage of a mouse model of experimental autoimmune diabetes","author":"Bru-Tari","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2020.154137_bb0730","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.devcel.2013.05.018","article-title":"Adult duct-lining cells can reprogram into beta-like cells able to counter repeated cycles of toxin-induced diabetes","volume":"26","author":"Al-Hasani","year":"2013","journal-title":"Dev Cell"},{"key":"10.1016\/j.metabol.2020.154137_bb0735","article-title":"Gene signature of proliferating human pancreatic \u03b1 cells","volume":"159","author":"Dominguez Gutierrez","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2020.154137_bb0740","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2002-020735","article-title":"Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea","volume":"88","author":"Yoon","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154137_bb0745","first-page":"29","article-title":"Multiplexed in situ imaging mass cytometry analysis of the human endocrine pancreas and immune system in type 1 diabetes","author":"Wang","year":"2019","journal-title":"Cell Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520300019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520300019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:41:50Z","timestamp":1779306110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520300019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":149,"alternative-id":["S0026049520300019"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154137","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154137"}}